LIFE ON KESIMPTA VIDEOS

YOU’VE GOT THIS
RMS can be really hard, but you’re not alone. The KESIMPTA Crew has been there, and now they’re sharing what helped them move forward.
Watch their videos to see the steps they took.
THE KESIMPTA CREW TALKS: Life on KESIMPTA
Why We Chose KESIMPTA
Zenovia and Andy share why they decided KESIMPTA was right for them.
How KESIMPTA Fits Our Lives
Caylee, Zenovia, Andy, Karina, and Brittany share ways KESIMPTA can fit their busy lifestyles.
Why We Love the Pen
Brittany, Caylee, and Andy share their first impressions of the auto-injector pen, and their favorite features.
How To Take KESIMPTA
Zenovia shows you how to use the auto-injector pen, step-by-step.
Traveling with KESIMPTA
Candice explains how you can travel with KESIMPTA—even on treatment day.*
*KESIMPTA pens must be refrigerated at 2 °C to 8 °C (36 °F to 46 °F). Keep product in the original carton to protect from light until the time of use. Do not freeze. To avoid foaming, do not shake. If necessary, KESIMPTA may be stored at room temperature below 30 °C (86 °F) for up to 7 days and returned to the refrigerator, to be used within the next 7 days. If not used within those 7 days, discard the medicine.
THE KESIMPTA CREW TALKS: Living With RMS
How RMS Impacted Our Families
RMS doesn’t just affect the person diagnosed—it touches everyone who cares. Karina, Caylee, Brittany, and their families share how facing each day together as a team can make all the difference.
How RMS Impacted Our Careers
Zenovia, Andy, and Luis share how they’ve adapted since diagnosis—navigating tough conversations on the job and finding a fresh work-life balance.
How RMS Impacted My Dating Life
Caylee shares her new approach to relationships since diagnosis.

Up Next:
Explore what additional support may be available to you.
Want more info to help you decide?
Find out why so many people are choosing KESIMPTA.
Want co-pay help?
96% of all prescriptions filled paid as little as $0 out of pocket cost when used with the Co-Pay Plus offer.†‡
All people featured on this webpage are living with relapsing multiple sclerosis, have taken KESIMPTA, and have been compensated for their time.
RMS, relapsing multiple sclerosis.
†Limitations apply. Valid only for those with private insurance. The Program includes the Co-Pay Plus offer, Plus Card (if applicable), and Rebate, with a combined annual limit up to $18,000. Patient is responsible for any costs once limit is reached in a calendar year. Program not valid (i) under Medicare, Medicaid, TRICARE, VA, DoD, or any other federal or state health care program, (ii) where patient is not using insurance coverage at all, (iii) where the patient’s insurance plan reimburses for the entire cost of the drug, or (iv) where product is not covered by patient’s insurance. The value of this program is exclusively for the benefit of patients and is intended to be credited towards patient out-of-pocket obligations and maximums, including applicable co-payments, coinsurance, and deductibles. Program is not valid where prohibited by law. Patient may not seek reimbursement for the value received from this program from other parties, including any health insurance program or plan, flexible spending account, or health care savings account. Patient is responsible for complying with any applicable limitations and requirements of their health plan related to the use of the Program. Valid only in the United States and Puerto Rico. This Program is not health insurance. Program may not be combined with any third-party rebate, coupon, or offer. Proof of purchase may be required. Novartis reserves the right to rescind, revoke, or amend the Program and discontinue support at any time without notice.. See complete Terms & Conditions at start.kesimpta.com.
‡2025 data on file.
RMS, relapsing multiple sclerosis.
†Limitations apply. Valid only for those with private insurance. The Program includes the Co-Pay Plus offer, Plus Card (if applicable), and Rebate, with a combined annual limit up to $18,000. Patient is responsible for any costs once limit is reached in a calendar year. Program not valid (i) under Medicare, Medicaid, TRICARE, VA, DoD, or any other federal or state health care program, (ii) where patient is not using insurance coverage at all, (iii) where the patient’s insurance plan reimburses for the entire cost of the drug, or (iv) where product is not covered by patient’s insurance. The value of this program is exclusively for the benefit of patients and is intended to be credited towards patient out-of-pocket obligations and maximums, including applicable co-payments, coinsurance, and deductibles. Program is not valid where prohibited by law. Patient may not seek reimbursement for the value received from this program from other parties, including any health insurance program or plan, flexible spending account, or health care savings account. Patient is responsible for complying with any applicable limitations and requirements of their health plan related to the use of the Program. Valid only in the United States and Puerto Rico. This Program is not health insurance. Program may not be combined with any third-party rebate, coupon, or offer. Proof of purchase may be required. Novartis reserves the right to rescind, revoke, or amend the Program and discontinue support at any time without notice.. See complete Terms & Conditions at start.kesimpta.com.
‡2025 data on file.

